New! View global litigation for patent families

WO1993006775A1 - Method and apparatus for determining oxygen saturation - Google Patents

Method and apparatus for determining oxygen saturation

Info

Publication number
WO1993006775A1
WO1993006775A1 PCT/US1992/008396 US9208396W WO1993006775A1 WO 1993006775 A1 WO1993006775 A1 WO 1993006775A1 US 9208396 W US9208396 W US 9208396W WO 1993006775 A1 WO1993006775 A1 WO 1993006775A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
blood
light
saturation
oxygen
hematocrit
Prior art date
Application number
PCT/US1992/008396
Other languages
French (fr)
Inventor
Eric Fogt
Jeffrey Lund
James Kelley
Original Assignee
Medtronic, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14535Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring haematocrit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14557Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted to extracorporeal circuits
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607Regulation parameters
    • A61M1/3609Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/361Physical characteristics of the blood, e.g. haematocrit, urea before treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3607Regulation parameters
    • A61M1/3609Physical characteristics of the blood, e.g. haematocrit, urea
    • A61M1/3612Physical characteristics of the blood, e.g. haematocrit, urea after treatment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths

Abstract

Blood is passing through a blood circuit where it is exposed to light at red and infrared wavelength. The amount of light reflected is measured at a single distance from the provided infrared light and is used to calculate the hematocrit level. Oxygen saturation is then calculated. In another method, different formulas are used, selected according to the oxygen saturation and/or the hematocrit level. In one embodiment, hematocrit level is determined using measurement of reflected infrared light at the isobestic wavelength of oxy- and deoxyhemoglobin. In another, hematocrit level is determined using measurements of reflected infrared light at two wavelenghts symmetrically disposed about the isobestic wavelength in order to approximate the measurement at this point. The oxygen saturation calculation is based in part on the ratio of the measurement at an infrared wavelength to a separate one measured at a red wavelength. Particular apparatus including LEDs (20, 22, 24), fiber-optic cables (5) is also disclosed, together with instrumentation (3) for operating the device and effecting the determinations.

Description

METHOD AND APPARATUS FOR DETERMINING OXYGEN SATURATION

BACKGROUND OF THE INVENTION

Field of the Invention

This invention relates to fiber-optic sensors for determining oxygen saturation and hematocrit of the blood as it flows through an extracorporeal blood circuit in which it is oxygenated during bypass surgery and the like.

Description of the Prior Art

Fiber-optic sensors for the determination of oxygen saturation (amount of oxygenated hemoglobin), and/or the determination of hematocrit (amount of red blood cells), in the blood in an extracorporeal circuit or otherwise are disclosed in U.S. Patents 4,444,498, 4,447,150, 4,651,741, 4,745,279, 4,776,340 and others. Many such sensors function by providing light to the blood sample via a fiber-optic cable, and measuring the amount of reflected or transmitted light. Light-emitting diodes (LEDs) have been used in these devices to provide radiation at given wavelengths to the sample via the fiberoptic input cables; other fiber-optic cables have transmitted the light reflected by or transmitted through the sample at those wavelengths to photodiodes to produce a current proportionate to the reflected or transmitted light. In general, the LEDs alternately, or in series, emit light of one wavelength and then another. See Heinemann, U.S. Patent 4,444,498, Lavallee, U.S. Patent 3,647,299, Goldring, U.S. Patent 4,684,245. The calculation of both hematocrit and oxygen saturation allow calculation of approximately the total oxygen content of the blood.

Hematocrit has been calculated in such devices from a ratio of the amount of light reflected from the blood at two different distances from the light source; the isobestic point on the oxy and deoxyhemoglobin reflection curves (about 820 nm) is the wavelength suggested because it is not influenced by the oxygen saturation level. Two detectors are used to receive the reflected light at two different distances from the source, all as disclosed in Moran, U.S. Patent 4,776,340, and Schmitt, et al. An Integrated Circuit-Based Optical Sensor for In Vivo Measurement of Blood Oxygenation, Vol . BME-33, No . 2 IEEE: Transactions on Biomedical Engineering, February 1986.

In Steinke, et al. , Reflectance Measurements of Hematocrit and Oxyhemoglobin Saturation, American Journal Physiology 1987, pp H147 to H153 and Schmitt, et al., New Methods for Whole Blood Oκimetry 1986, Pergamom Press Ltd., hematocrit is similarly determined, but with two sources at different distances from a single detector. These systems always, however, require three channels to calculate hematocrit, either two source channels and one detector or vice versa. In the Schmitt article, it is further required that the "near" measurement be taken at a higher wavelength than the "far" one. In Karkar, U.S. Patent 4,745,279, hematocrit in a blood circuit is determined by measuring light diffused by the blood, the light being provided by an LED source adjacent the blood at the isobestic wavelength. A correction is then made for oxygen saturation, and a look-up table used to determine true hematocrit.

In sensors for oxygen saturation, often called oximeters, oxygen saturation has been determined using a number of different equations based on input of light at about 665 nm and about 820 nm, such as: sO2 = A+B(Ratio0) and sO2 = A-B (Ratio0) where ,

These equations may depend on the configuration of the particular device. 665 nm is a point of large difference between absorption of deoxyhemoglobin and oxyhemoglobin on the reflection curves; 820 nm or thereabouts is an isobestic point at which the absorption is identical for both compounds.

It was originally thought that the reading at the 820 nm isobestic point in the oxygen saturation calculation would compensate for varying optical density. It was also thought to compensate for varying hematocrit levels because saturation of hemoglobin with oxygen does not influence the amount of reflected light at that point; see Heinemann, U.S. Patent 4,447,150.

However, it has been determined that oxygen saturation results may be inaccurate in certain ranges unless further compensation is made for blood variation. In Shaw, U.S. Patent 4,114,604 and Lubbers, et al., U.S. Patent 3,825,342, a third wavelength is used as well in the measurement of oxyhemoglobin to correct for variability in the blood. In Takatani, et al., A Miniature Hybrid Reflection Type Optical Sensor for Measurement of Hemoglobin Content and Oxygen Saturation of Whole Blood, 35 IEEE: Transactions on Biomedical Engineering 3, March 1988, correction for blood variability was made by adding a constant to the denominator and sometimes also the numerator of Ratio0, the constant being fixed based on blood characteristics and sensor geometry. In Shaw, et al., U.S. Patent 3,847,483, two non-isobestic wavelengths are used for measuring oxygen saturation using a more complex equation, in order to yield a measurement thought to be independent of blood variation.

In Steinke and Shepherd, Reflectance Measurements of Hematocrit and Oxyhemoglobin Saturation, American Journal Physiology, 1987, pp H147 to H153, the oxygen saturation figure is corrected for hematocrit by calibrating constants used in the oxygen saturation determination according to the hematocrit level. This approach, however, does not allow correction if hematocrit changes, and thus may introduce error into the system.

The latter of the two Schmitt articles. New Methods for Whole Blood Oximetry, 1986, Pergamom Press Ltd. discloses an oxygen saturation measurement made from a device having two identical infrared sources at different distances from the detector, as well as a red light source. Oxygen saturation is measured based on reflected light at these wavelengths using a look-up table which appears to provide an oxygen saturation measurement corrected for variability in hematocrit. However, the Schmitt device requires the separate development and input of a particular look-up table not only for each instrument, but for each blood-contacting unit used, a lengthy and time- consuming process for any device which is manufactured on other than a custom basis, or which uses disposable blood-contacting units.

Passafaro, U.S. Patent 4,651,741, discloses corrections for hematocrit made using the following equation: sO2 = Ak2I2 + Bkl + C, where k is a calibration constant and hematocrit is separately measured in the laboratory. In Passafaro, A, B and C are values based on the hematocrit level, contained in a look-up table, and accessed during the calculation. Since laboratory measurements are not instantaneous, the red blood cell level in the blood in the circuit can change radically without a change in the correction factor, resulting in what might be substantial error in the resulting oxygen saturation measurement.

Moran, et al., U.S. Patent 4,776,340 discloses a catheter system in which hematocrit is calculated based on the ratio of reflected infrared light measured at two different distances from the source. No particular wavelength is suggested; instead it is advised not to try to use the isobestic wavelength for the measurements, but to make a correction in the hematocrit calculation instead. An oxygen saturation calculation includes a compensation for the hematocrit so calculated.

In Shaw, U.S. Patent 4,114,604, two red wavelengths and one infrared are used in the calculation of oxygen saturation in order to minimize its dependence on blood conditions such as hematocrit. The system described includes electronics for calculating oxygen saturation according to two different formulas, depending on the level of oxygen saturation.

Sperinde, et al., U.S. Patent 4,623,248 discloses a fiber- optic catheter oximeter in which the oxygen saturation level of the blood is computed by deriving it with a formula which uses the ratio of one pair of intensity signals when the oxygen saturation level is relatively low and with a formula which uses the ratio of another pair of intensity signals when the oxygen saturation level is high. This, however, while minimizing the effect of hematocrit on the measurement, does not correct for it. Further, it always requires the use of three distinct wavelengths and corresponding LEDs ╌ two in the red and one in the infrared. The above description of art is not intended to constitute an admission that any patent, publication or other information referred to is "prior art" or is enabling with respect to this invention, unless specifically designated as such. In addition, this section should not be construed to mean that a search has been made or that no other pertinent information as defined in 37 C.F.R. § 1.56(a) exists.

Overall, it would be desirable to provide an easily-manufacturable device and a method which provides an oxygen saturation measurement at desired accuracy levels by compensating as necessary for blood variability.

SUMMARY OF THE INVENTION

The present invention is a method and apparatus for determining oxygen saturation in blood passing through a blood circuit which avoids many of the problems associated with prior methods and devices.

In one aspect, the invention is a method of determining oxygen saturation in blood passing through a blood circuit. The method includes the following steps:

providing light to the blood as it passes through the circuit,

receiving light reflected from the blood at a single distance from the provided light,

utilizing the received light to make a representation or approximation of the amount of light reflected from the blood at the isobestic point, calculating the hematocrit level of the blood passing through the circuit using the representation or approximation made above, and

calculating oxygen saturation in the blood passing through the circuit based on the hematocrit calculation so that the oxygen saturation calculation includes a correction for the hematocrit level calculated as above.

In this aspect, the method of determining oxygen saturation provides an oxygen saturation determination which includes compensation for the hematocrit level of the blood actually concurrently passing through the circuit, without the difficulties of a look-up table or a near/far hematocrit determination.

In this aspect, the light is generally provided at one infrared wavelength and the amount of the infrared light reflected from the blood is measured. Sometimes two infrared wavelengths symmetrically disposed about the isobestic wavelength of oxy- and deoxyhemoglobin are used and the amount of each, reflected from the blood at the same distance from the source, is measured. Generally, red light is also provided to the blood and the amount reflected is measured, so that the oxygen saturation calculation can also be based on the ratio of the amount of infrared-to-red reflected light. In another aspect, the invention is a method of determining oxygen saturation of the blood which includes the following steps:

providing infrared light to the blood,

providing red light to the blood,

measuring the amount of infrared light returned from the blood,

measuring the amount of red light returned from the blood,

utilizing the measurement of infrared light to calculate hematocrit level, and

calculating oxygen saturation using the following formula:

E, F, G, H, I, J, K are constants, Hct is the percent hematocrit, and Ratio is the ratio of the measurement of infrared-to-red light returned. This approach has been found to provide a particularly accurate oxygen saturation determination. In another aspect, though, a different formula is used in the invention, as follows:

N, O, P, Q, S, and T are constants. In another aspect, the invention is a method of determining oxygen saturation by using different formulas for the oxygen saturation calculation according to the level of oxygen saturation and/or the level of hematocrit. In one version of this aspect of the invention, the invention includes th following steps:

repeatedly measuring light at a wavelength in the red range reflected from the blood as it passes through the blood circuit,

repeatedly measuring light at a wavelength in the infrared reflected from the blood as it passes through the blood circuit,

repeatedly calculating hematocrit level in the blood as it passes through the blood circuit based on the measurements of infrared light, and

repeatedly determining oxygen saturation in the blood based on the hematocrit level, using more than one formula for the determination according to the level of oxygen saturation. This method of determining oxygen saturation is believed to minimize inaccuracies in the result. In another version of this aspect of the invention, the invention includes the following steps:

repeatedly measuring light at a wavelength in the red range reflected from the blood as it passes through the blood circuit,

repeatedly measuring light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit,

repeatedly calculating oxygen saturation in the blood based on the measurements above, using a different formula for the determination of oxygen saturation depending on the level of hematocrit in the blood. The oxygen saturation calculation also includes a correction for the hematocrit level of the blood. This approach is believed to minimize inaccuracies in the determination of oxygen saturation.

Specific formulas are provided for the calculations of oxygen saturation and hematocrit in the preferred embodiment of these aspects of the invention. Two preferred formulas for the calc ulation of hematocrit follow.

Hct = Exp (L · RISOBESTIC + M/Ln ( RISOBESTIC 2) )

Also, it should be noted that in one preferred approach, hematocrit is calculated based on a single measurement of reflected light at about the isobestic wavelength. In another preferred approach, it is calculated using measurements of reflected light at wavelengths symmetrically disposed about the isobestic point. In the latter case, the amount of light reflected at the isobestic point is approximated by measuring the amount reflected at the different infrared wavelengths and approximating or making a representation of the amount reflected at the isobestic point. The following formulas are preferred for making this approximation and are preferably used when light is provided and measured at two infrared wavelengths:

or

RISOBESTIC = RFIRS T INFRARED X RSECOND INFRARED

In yet another aspect, the invention includes an apparatus for determining oxygen saturation in blood passing through a blood circuit. The apparatus includes:

means for repeatedly providing light to the blood as it passes through the blood circuit,

means for repeatedly receiving light reflected from the blood at a single distance from the provided light,

means for repeatedly utilizing the received light to approximate the amount of light reflected from the blood at the isobestic wavelength of oxy- and deoxyhemoglobin, means for repeatedly calculating the hematocrit level of the blood passing through the blood circuit based on the amount of light reflected from the blood at the isobestic wave1ength, and

means for repeatedly calculating oxygen saturation in the blood passing through the blood circuit based on the amount of light reflected from the blood and the calculation of hematocrit so that the oxygen saturation determination includes compensation for the hematocrit level of the blood passing through the circuit, calculated as indicated. Preferably the light is at an infrared wavelength, most preferably at or near the isobestic point.

In this aspect, the apparatus preferably also includes:

means for repeatedly providing light at a red wavelength to the blood,

means for repeatedly measuring the amount of red light reflected from the blood as the blood passes through the blood circuit, and

means for repeatedly measuring the amount of infrared light reflected from the blood as it passes through the blood circuit, where the means for calculating oxygen saturation utilizes the measurements of red and infrared light.

In another aspect, the invention is apparatus for measuring oxygen saturation which includes: means for repeatedly measuring light at a wavelength in the red range reflected from the blood as it passes through the blood circuit,

means for repeatedly measuring light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit,

means for repeatedly calculating hematocrit level in the blood as it passes through the blood circuit based on the infrared measurement, and

means for repeatedly determining oxygen saturation in the blood based on the above measurements and the hematocrit calculation, and selecting a different formula for the determination according to the level of oxygen saturation.

Preferably, the apparatus in this aspect includes means for selecting the oxygen saturation formula according to the hematocrit level as well. The hematocrit calculation is usually made using an approximation or representation of the amount of light reflected at the isobestic wavelength, and, in certain embodiments, is made using an actual measurement of the amount of light reflected at the isobestic wavelength.

In yet another aspect, the invention is apparatus for determining oxygen saturation in blood in a blood circuit. The apparatus includes: means for repeatedly measuring light at a wavelength in the red range reflected from the blood as it passes through the blood circuit,

means for repeatedly measuring light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit, and

means for repeatedly calculating oxygen saturation in the blood based on the measurements, using a different formula for the determination of oxygen saturation according to the level of hematocrit in the blood.

Preferably, the apparatus in this aspect also includes means for repeatedly calculating hematocrit level of the blood as it passes through the circuit and the means for calculating oxygen saturation includes means for correcting the oxygen saturation calculation for the hematocrit level. The means for calculating hematocrit includes a means for approximating the amount of reflected light at the isobestic wavelength of deoxy- and oxyhemoglobin.

In all the above apparati, the means for providing light are preferably light-emitting diodes, the means for measuring the amount of light is a photodiode, and the means for calculating is software. Generally, the blood is passed through a cuvette and the diodes provide and receive light through fiber-optic cables, the emitting cables being equidistant from the receiving cables at the blood or cuvette interface. In general, the LEDs emit light sequentially and a central processing unit controls the apparatus.

Preferably the wavelength of the infrared light is either at about the isobestic wavelength of oxy- and deoxyhemoglobin, or is at two wavelengths symmetrically disposed about the isobestic wavelength, most preferably at 810 and 830 nm. In the latter case, the software provides one of the above- mentioned two formulas for approximating or representing the amount of reflected light at the isobestic point. The software also provides specific formulas for the calculations of oxygen saturation and hematocrit in the preferred embodiment of these aspects of the invention. Two formulas for the calculation of oxygen saturation and for hematocrit are mentioned above. In the above aspects, as well as in other aspects, the present invention provides an advantageous method and apparatus for determining oxygen saturation which avoids problems associated with various prior methods and devices.

BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is an overall illustration of the entire apparatus. Fig. 2A is a plan view of the end of the fiber-optic cable where it attaches to the cuvette. Fig. 2B is a longitudinal cross-section of the cuvette attached to the cable.

Fig. 3A is a cross section of the bulkhead connector between the cable and the instrument. Fig. 3B is an enlargement of the area where the fiber-optic channels connect and Figs. 3C and 3D are isometric end views of the two parts of the bulkhead connector.

Fig. 4A is a longitudinal cross-section of the cuvette. Fig. 4B is a cross-section of the cuvette taken at lines 4B-4B of Fig. 4A. Fig 4C is a top view of the cuvette and window. Fig. 4D is a cross-section of the calibration cuvette.

Fig. 5A is a cross-section of the lock or latch mechanism attaching the cuvette to the main cable; Figs. 5B and 5C are enlargements. Fig. 5D is a side elevation of the latch mechanism.

Figs. 6A and 6B form a system block diagram for the apparatus.

Figs. 7A and 7B are flow charts, respectively, of the software for the "Calibrate" mode and the "Run" mode. Figs. 8A and 8B are tables of partitioned equations for the determination of oxygen saturation. Fig. 8C is a flow chart of software performing the oxygen determinations using the partitioned equations of Fig. 8A, and Fig. 8D is a flow chart of software using the partitioned equations of Fig. 8B.

Fig. 9 is a graph of the reflection curves of deoxygenated and oxygenated hemoglobin showing the isobestic point.

DETAILED DESCRIPTION OF THE SPECIFIC EMBODIMENTS

The present method of determining oxygen saturation is accomplished using the oximetric device described here.

I. Overall Fiber-optic Sensor System

The preferred embodiment of the system 1 shown in Fig. 1 includes an instrument or electronic module 3 housing LEDs, photodetectors, and hardware and software. Two non-disposable fiber-optic cables 5 and two cuvettes 7a and 7b, which are placed in the blood stream path, are included so that oxygen saturation and hematocrit in blood passing through the cuvettes in the extracorporeal blood circuit can be measured. A printer (not shown) can be attached to the module or housing 3. One cuvette 7a is located in the venous flow path and one, 7b, is located in the arterial flow path, so oxygen saturation and hematocrit of both can be monitored and displayed. The device is physically and operationally identical for both the arterial and venous paths, except where indicated below; therefore only one of the two paths is described below unless specific description of the other path is necessary.

II. Fiber-optic Cable

Referring to Figs. 2A and 2B, the preferred cable 5 includes four fiber-optic channels. The fiber-optic channels are formed of polymethyl methacrylate with fluorinated polymer cladding obtained from PolyOptical Products, Inc., Santa Ana, California. One is an emitter channel 10 for transmitting 660 nm radiation from a 660 nm LED (20 in Fig. 6A) to the blood sample; a second is an emitter channel 12 transmitting 810 nm infrared radiation from an 810 nm LED (22 in Fig. 6A) in module 3, to the blood sample; a third is an emitter channel 14 transmitting 830 nm IR radiation from an 830 nm LED (24 in Fig. 6A) in module 3 to the blood sample. A single LED at the true isobestic wavelength (about 820 nm) and a single corresponding channel can be chosen, if available, to avoid the need for both the 810 and 830 nm channels. These emitter channels transmit the radiation through the window of the cuvette 7, discussed below, to the blood sample, illuminating the blood.

The fiber-optic cable 5 also includes a fourth channel 16 for receiving reflected radiation at the input wavelengths, and transmitting it to a signal photodetector 258 (shown in Fig. 6A) in the electronic module. This preferred embodiment measures reflected light, as indicated, but it is within the scope of the invention to measure transmitted light instead, in the case of an appropriate device.

At the distal end of the cable, the fiber-optic channels are spaced with the emitter channels equidistant from detector channel 16, as shown in Fig. 2A. The preferred fiber-optic channel size for all the emitter channels is .030 inches in diameter, the detector channel is preferably .040 inches in diameter and the emitter channels are preferably located about .047 inches from detector channel 16. For a particular device, the distance of the emitter channels from the detector channel at the blood interface can be optimized using methods known in the art.

III. Bulkhead Connector

The proximal end of the cable is attached to instrument 3 via a bulkhead attachment 30 shown in cross-section in Figs. 1 and 3A, and in 3B and 3C. A round female unit 32 having interior threads 34 and a key 36 is rotatable with respect to the cable. A male unit 38 with threads 31, mounting unit 7 for mounting in housing 3, and key slot 35 is disposed in module 3.

To connect the cable to the module, the male unit is placed within the female unit, key slot to key, and the female unit 32 is rotated to attach the cables to the bulkhead, companion fiber-optic channels not more than .010 inches apart from each other. An enlargement of the connection is shown in Fig. 3B, with a small space 33 between the companion channels.

IV. Cuvette

A cuvette 7a or 7b shown in Figs. 2B, 4A, 4B, and 4C is placed within the extracorporeal blood path for blood flow therethrough during bypass surgery. The blood flows longitudinally through the cuvette through axial cavity 50. The cuvette is molded of polycarbonate for convenient light transmission and is of generally cylindrical shape. Barbed fittings 51 at each end are designed to fit within the tubing of the extracorporeal circuit with a leak-free seal.

V. Latch Connector

When in use, the cuvette is attached to the cable via lock or latch 70 shown in Figs. 2A-B. On cable 5, the lock includes knob 72 rotatable with respect to foot 73 containing the fiber-optic channels. Foot 73 has stops 74 and 76 which limit rotation of knob 72 when they contact extensions 78 and 80. Springs 81 bias foot 73 away from cable 5. Stops 74 and 76 contain key slots or channels 82 and 84, preferably of different sizes. Extensions 78 and 80 together with stops 74 and 76 define an area of rotation of knob 72; the knob can be rotated so that the key slots are located at a position A or a position B as shown. Adjacent the key slots when they are located in position B are lips 86 and 88, each with its own stop 90 and raised lock 92. Cuvette 7 contains keys 94 and 96, each designed to be received in one of slots 82 or 84; space 95 between them is designed to receive foot 72. Each key defines an aperture 98 and flange 97 which can receive a lip 86 or 88. The cuvette is attached to the cable by sliding the keys into the appropriate key slots when knob 72 is in position A. Cuvette 7 and foot 73 are then urged toward the cable and the knob rotated so that cuvette flanges 97 pass over locks 92 and reach stops 90 with the knob in position B. Pressure on the cuvette and foot is then released and spring 81 in cooperation with locks 92 firmly hold the channel and cuvette in place with channels 10, 12, 14, 16 abutting window 52 of the cuvette.

VI. System Block Diagram

A system block diagram for the entire device is shown in Figs. 6A and 6B. Bulkhead connector 30 contains three optical channels 250, 252, and 254 to conduct LED illumination to the bulkhead. It also contains one optical channel 256 to conduct reflected signal energy to the signal detector 258 and one optical channel 260 to conduct disconnect signal energy to the disconnect detector 262.

Signal detector 258 is connected to the signal detector amplifier 264 that amplifies the signal in a range usable for the analog-to-digital converter 266. The analog-to-digital converter data is fed to the CPU 270.

Optical channels 250, 252, and 254 are coupled to individual LEDs 20, 22 and 24 of the three wavelengths 660 nm, 810 nm, and 830 nm, respectively. Each. LED is energized by its LED driver, shown as one of 274a, b, or c on Fig. 6A. Each LED driver is individually turned on and off by the CPU.

The intensity of each LED is controlled by an individual compensation circuit. Each compensation circuit consists of a compensator detector, one of 276a, b, or c to monitor the LED energy. Each compensator detector is coupled to a compensator detector amplifier, one of 278a, b, or c, which amplifies the signal. Each compensator detector amplifier signal is coupled via a multiplexer, a comparator-integrator and another multiplexer to the appropriate LED driver 274a, b, or c. If the LED energy varies from its set point, this information is fed to the LED driver and the LED driver adjusts the LED energy as necessary to maintain the set point.

In operation, individual LED energies are sequentially triggered to illuminate the sample via cable 5. The reflected energy from the sample is transmitted through the detector channel 16 in cable 5 to the signal detector 258. The signal is amplified by the signal detector amplifier 264, converted to digital data via the analog digital converter 266, and read by CPU 270. Preferably, the individual LEDs are triggered So that the detector reads first the "ambient" light received along the channel and then reads the reflected light at the LED wavelength. The "ambient" data is subtracted from the reflected data in the software before correction for calibration.

Referring now to Fig. 6B, the CPU 270 is a standard 8-bit micro-controller with RAM 280, ROM 282, a watch dog timer 284, and an asynchronous serial port 286 for attachment to printer 2 in this case. Additional system components are the power supply 288, an LCD display 290, a test switch 292 and an event switch 294 all connected to the CPU.

VII. Software

A. Calibration

When the device is first used, it is calibrated to compensate for variations in the individual system's optical components; by taking measurements under known conditions, normalization factors can be determined for each LED emitter channel and detector channel combinations. Such factors are developed to correct the raw readings at each channel for variations inherent in each system.

Calibration is accomplished in the preferred embodiment using a calibration cuvette 500 shown in Fig. 4D. This is a cuvette designed to be attached to the cable unit in the same fashion as a standard cuvette. However, it contains a material designed to provide a known amount of reflected light in the device at the selected wavelengths.

The calibration cuvette does not contain a chamber for blood passage; instead, it contains a well 502 to contain reflective material 504. Preferably, for simplicity of manufacture, it otherwise duplicates the standard cuvette as much as possible. Also, it terminates in two bases 506 and 508 which are permanently adhesively attached to the instrument module 3 for convenience of use for each calibration. Material 504 is designed to resemble blood in that the amount of light reflected is similar to that of blood. Since the preferred device is designed to operate maximally with blood giving a signal of about 2.0 to 3.0 volts, the preferred calibration standard gives a signal in this range also.

In an attempt to maximize accuracy of the calibration, the device is preferably calibrated using a calibration standard (material 504) providing a voltage just above the maximum reflected voltage level for blood. Using as high a voltage as possible within the desired level minimizes the effect of errors in the calibration reading on the normalization factors which calibration creates. The maximum voltage read from blood in the preferred embodiment at the 660 nm wavelength is about 2.8 volts while the maximum at the 810 and 830 nm wavelengths is about 2.5 volts. In the preferred embodiment, thus, the calibration standard reflects at a level equivalent to 3.0 volts on the 660 nm channel

and 2.5 volts on the 810 and 830 nm channels.

The material used for the calibration includes a light- scattering agent dispersed at desired levels in a support medium. The support matrix is substantially non-light- absorbing at the wavelengths of interest and may be formed of a number of materials such as silicone elastomers (like Dow Coming's Silastic MDX 4-4210), urethanes, epoxy, or other materials. The support matrix is generally chosen for certain characteristics. Specifically, it should cure to a solid fairly quickly without allowing the dispersed materials to settle out. Once cured, its viscosity and other features should be stable over time. The preferred support matrix is epoxy which shows limited degradation over time.

A number of light-scattering materials can be used such as titanium dioxide, Tempera paint pigment, silicon carbide, ferric oxide, etc., which can be evenly dispersed in the matrix. These materials should be generally non-varying over time and, if possible, of a uniform particle size.

In some embodiments, dyes may be used to diminish the reflected light at certain wavelengths. These dyes may be included in the support matrix or may be independently dispersed. Some possible dyes are PSP030, a blue pigment dispersion made by Huls Petrarch, Inc., or Thymol blue made by Fisher Chemical Company. The blue dyes will reduce the amount of reflected red light. The preferred material, specifically, will include about::

59.4% by weight Epoxy resin

35.6% by weight Epoxy hardener

5.0% by weight Titanium dioxide powder

The preferred epoxy is Hexcel Epolite 3310, a 75 Shore D clear epoxy.

The preferred titanium dioxide (or Titanium (IV) Oxide) is a white powder of greater than 99.9% purity in the anatase form.

The mixture is cured in the cavity 502 of calibration cuvette 500 shown in Fig. 4D and is preferably about 1/4 inch thick, or at least thick enough and sufficiently opaque so that ambient light does not enter from the rear.

The calibration constants in the preferred device, 3.0 volts for the 660 nm channel, 2.5 volts on the 810 channel, and 2.5 volts on the 830 nm channel are used to calculate normalization factors as follows:

For example, if the voltage read on the 660 channel using the standard is 2.9, the normalization factor for that channel is: If, for example, on the other two channels, the voltage on the 810 nm channel during calibration is 2.4 and that on the 830 channel is 2.3, the normalization factor for each will be:

and These factors are stored in RAM as the normalization factors for each channel, and thus readings on each channel are separately calibrated and corrected for variability of the system.

A software flow diagram for the calibration process is shown in Fig. 7A.

The CPU first displays "Cal" in the arterial and venous windows 292 to prompt the operator to depress the Test switch 290, and waits for the switch to be held for at least 3 seconds, steps 300, 302 in Fig. 7A. The LED drivers are then directed to energize the LEDs sequentially, step 304.

Data is acquired on the venous and arterial channels at each wavelength as follows. Detector voltages are captured for each wavelength on the venous channel in the hardware capture circuitry described previously. Each captured venous voltage is digitized and stored in RAM in the venous data table, step 304. The same steps are taken for the arterial channel, step 350.

Normalization factors are calculated for each wavelength by the CPU using the acquired data, steps 308, 352. Raw data and the normalization factors are then compared to preset limits for validation, steps 306, 310, 350, 354. If either channel is found to be invalid, the CPU blanks the display. If both channels are invalid, a "Fail" flag is set (and displayed), the "Cal" flag is redisplayed and the procedure must be restarted, steps 314, 358, or problems with the device corrected. If the venous channel data and normalization factor are found to be valid, an active channel flag is set; the same is done for the arterial channel, step 356. A "Pass" flag is then set and displayed, step 360. If one of the channels is invalid, its display window is blanked. In use, the CPU uses the normalization factors for each channel to correct raw readings before calculating hematocrit and oxygen saturation via software contained in RAM.

B. Run Mode

After calibration, the device operates in the "Run" mode. All variables, flags and registers are initialized for the run mode and normalization factors are included. The run mode is the normal operational mode for the instrument that is active until the device is powered down. An itemization of one run mode cycle after initial testing (step 400, as described above) is then shown in Fig. 7B.

The detector voltages are captured and processed as described in the calibration section above, steps 402, 404, 450, 452. The output is the venous data table which contains values for each wavelength and the arterial data table, which also contains output for each wavelength.

The venous data is processed as follows. If the venous channel is not active, the procedure is exited, 402, and arterial procedure entered. If active, the venous channel data is compared to acceptable limits, 406. If the venous data is not valid, an error message is displayed in the venous display window, 414, and the procedure is exited. If valid, the data (which has already been corrected for ambient signals) is adjusted for VCO non-linearities. Finally, the data for each channel is then normalized, using the normalization factors obtained in the calibration mode. This is done by multiplying the received data by the multiplicative scale factor determined during calibration. For example, in the example shown, the received data on the 660 channel will be multiplied by 1.03, on the 810 channel by 1.04, and on the 830 channel by 1.09. Calculation of hematocrit and then oxygen saturation is then completed as described later using the normalized data. Venous saturation results produced as described above are then displayed, 410, 412. Arterial channel data is similarly processed, steps 462-462, but venous hematocrit is displayed, 416, if the channel is inactive. Otherwise, arterial saturation and hematocrit are displayed, 460. A printer can be used if desired, see 464-468.

VIII. DETERMINATION OF HEMATOCRIT AND OXYGEN SATURATION

A. Hematocrit

Where an LED is used which actually produces a wavelength at the isobestic point (about 820 nm) for hemoglobin and deoxyhemoglobin, that measurement is used in the calculation of hematocrit. Specifically, using the normalized data, a reflectance measurement RISOBESTIC OR RI is obtained, as follows for use in the measurement of hematocrit:

RI = R820

Otherwise, LEDs generating wavelengths symmetrically disposed about the isobestic point on the oxy-deoxyhemoglobin curve can be used to generate a representation of the amount of light reflected at the isobestic point. As can be seen on Fig. 9, if an LED generating the exact isobestic wavelength is not available in the device, two LEDs generating wavelengths disposed on either side of the isobestic point can be used1. The difference between the two curves at the one wavelength should be equal but opposite to the difference between the two curves at the other wavelength.

For example, in the preferred embodiment, LEDs generating wavelengths of 810 nm and 830 nm can be used, although other wavelengths such as 800 and 840 nm can be used. RISOBESTIC or RI can then be represented or approximated as follows:

or

RI = RFiRST INFRARED X RSECOND INFRARED

In the preferred embodiment, then

1It should be noted that LEDs used should be screened to determine actual wavelengths emitted, since the actual may not be the same as the labeled wavelength. Hematocrit (Hct) can then be calculated by using the RI value:

This equation, including constants A, B, C and D, was empirically derived by comparing RI values and their associated known hematocrit values, and is believed to provide very accurate measurements. In the preferred embodiment, the constants have been found to be as follows, using the first equation for RI provided above. Where the second equation for RI is used, a different set of constants must be generated, as is the case when RI is measured directly, using a wavelength at about the actual isobestic point on the curve.

A = 19.670148

B = 6.833192

C = 9.833347

D = 0.8262

Under abnormal physiological conditions (such as very unusual flow rates, pH, etc.), it may be desirable to use a modified equation which is believed to be more accurate under such conditions, e.g.:

This equation was developed by including such abnormal test data while generating the hematocrit calculation formula. L and M are constants generated for the device. B. Oxygen Saturation

Oxygen saturation is determined using a Ratio0 where:

R0 = RINFRARED X RRED

Specifically, here:

If an actual isobestic wavelength is used instead of the 830 nm LED, then 60

Oxygen saturation is then calculated as follows, where Hct is the hematocrit value determined above:

E through K are constants determined for the device before manufacture by comparing data from numerous such test devices to actual oxygen saturation figures.

Specifically, in the device shown,

E = 3.462727

F = 36.690131

G = 7.060379

H = 500.693864

I = 0.570215 J = 1425.89362

K = 7708.556902

Different constants will be generated where RISOBESTIC use rather than R830. This approach is believed to provide particularly accurate oxygen saturation data. Not only is the oxygen saturation data corrected for hematocrit variations, but it is also corrected for hematocrit which is measured essentially instantaneously. Furthermore, hematocrit is believed to be calculated very accurately via such actual or approximated reflectance at the isobestic point. Thus, variations in, and errors in the calculation of, the hematocrit level during a bypass procedure does not result in erroneous saturation readings. Again, to avoid error under abnormal physiological conditions in some embodiments, the .following modified calculation of oxygen saturation can be used:

sO2 = N'Ratio0 + O/Ratio0 + P/(Ratio0 2) + Q-Ratio0/Hct + S-Hct + T·Ln(Hct)

Determining sO2 in this fashion is believed to reduce sO2 error, particularly under abnormal conditions. N through are constants determined for the individual device. It was found possible to optimize the calculation of oxygen saturation by partitioning the response curves of the device and including abnormal values. Partitioning was done by both sO2 level and by hematocrit level to give sixteen formulas, four sO2 ranges in each of four hematocrit ranges. Partitioning only by hematocrit level provided four formulas. Fig. 8A contains sixteen particular equations found optimum for the calculation of sO2 in the preferred embodiment, partitioning by both Hct and sO2, when used in connection with bovine blood; Fig. 8B lists the four particular equations found optimum when hematocrit levels alone were used. Levels of hematocrit and sO2 as referred to in the Figures are as follows:

High Hct (level 1) = 33 - 40%

Medium high Hct (level 2)= 26 - 33%

Medium low Hct (level 3) = 21 - 26%

Low Hct (level 4) = 14 - 21%

High sO2 = 90 - 100%

Medium high sO2 = 70 - 90%

Medium low sO2 = 50 - 70%

Low sO2 = 30 - 50%

Software for incorporating the formulas of Figs. 8A and 8B in the device can be prepared by one of ordinary skill in the art. Sample flow charts, however, for such software are provided in Figs. 8C and 8D. It should be noted that in actually utilizing these equations, Ratio0 is used as an estimate of sO2 rather than the fully-calculated sO2 value. Also, in the figures (and the claims) Ratio0 is sometime referred to as "Ratio" or "Rat."

This approach is believed to further improve the accuracy of the sO2 determination, as indicated by a reduction in the standard deviation of the bias with the 4-block partition and a further reduction with the 16-block approach. (Data shows the reduction to be from 2.2 to 1.2 to 1.0.)

IX. Use of the Device

The device is first assembled before use, the second cable unit attached to the instrument using the bulkhead attachment and the cuvettes placed in what will be the extracorporeal circuit after it is primed. The cables are attached to the cuvettes using the latches. The device is then calibrated using the calibration cell provided, before priming. Once the system has been primed and is running, the device can be used to measure hematocrit and oxygen saturation. Using the equations set forth above, the device displays hematocrit readings and oxygen saturation readings. A printer can be activated to print readings if desired. Once the surgery is completed, the cuvette is removed from the circuit and disposed of, and the device readied for another use, with another cuvette, following the procedures described above. It will be understood that the above description and the illustrations are provided by way of example only, that alternate versions, equivalents, and examples will be apparent to those skilled in the art, and will be within the scope of the invention which is defined by the appended claims. For example, transmitted rather than reflected light can be measured with certain devices .

Claims

WHAT IS CLAIMED IS:
1. A method of determining oxygen saturation in blood passing through a blood circuit comprising the following steps:
a) providing light to the blood as it passes through the blood circuit;
b) receiving light reflected from the blood at a given distance from the provided light;
c) utilizing the received light to make an approximation of the amount of light reflected from the blood at the isobestic wavelength of oxy- and deoxyhemoglobin;
d) calculating the hematocrit level of the blood passing through the blood circuit using the determination of step c); and e) calculating oxygen saturation in the blood passing through the blood circuit based on the amount of light reflected from the blood and the calculation made in step d) so that the oxygen saturation determination includes a correction for the hematocrit level of the blood passing through the circuit, calculated according to the amount of light reflected at the isobestic wavelength of oxy- and deoxyhemoglobin.
2. A method of determining oxygen saturation in blood in a blood circuit according to claim 1 further comprising the following steps:
f) repeatedla providing light to the blood at a wavelength in the red range; g) repeatedly providing the light of step a) at a wavelength in the infrared range;
h) repeatedly measuring the amount of the red light reflected from blood, as the blood passes through the blood circuit;
i) repeatedly measuring the infrared light reflected from blood as the blood passes through the blood circuit; and
j) calculating oxygen saturation based on the results of steps e) and i).
3. A method according to claim 2 and wherein the wavelength of the infrared radiation is at about the isobestic point of oxy- and deoxyhemoglobin so that the measurement of step i) can be used as the approximation of step c).
4. A method according to claim 2 and further including the steps of k) repeatedly providing light at a second infrared wavelength to the blood and 1) repeatedly measuring the amount of the second infrared wavelength reflected from the blood at a single distance from the light provided, where the two infrared wavelengths are symmetrically disposed on different sides of the isobestic point.
5. A method according to claim 4 and wherein the determination of oxygen saturation includes the step of calculating the ratio of the measurement of step i) to the measurement of step h).
6. A method according to claim 2 and wherein different formulas are used in the determination of oxygen saturation according to the hematocrit level.
7. A method according to claim 2 and wherein different formulas are used for the determination of oxygen saturation according to the oxygen saturation level.
8. A method of determining oxygen saturation of blood in a blood circuit comprising the following steps:
a) repeatedly measuring light at a wavelength in the red range of the blood as it passes through the blood circuit; b) repeatedly measuring light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit;
c) repeatedly calculating hematocrit level in the blood as it passes through the blood circuit based on the measurements of step b);
d) repeatedly determining oxygen saturation in the blood based on the measurements of steps a), b) and c), using more than one different formula for the determination, depending on the level of oxygen saturation.
9. A method according to claim 8 further comprising the following steps
e) repeatedly providing red light to the blood;
f) repeatedly providing infrared light to the blood and wherein the formula is selected according to the hematocrit level.
10. A method according to claim 9 and wherein the wavelength in the infrared range is at the isobestic point on the reflection curves of deoxy- and oxyhemoglobin, so that the measurement of step b is used as the approximation of the amount of light reflected at the isobestic point.
11. A method according to claim 9 and further including the steps of repeatedly providing light at a second infrared wavelength to the blood and repeatedly measuring the amount of the second infrared wavelength reflected from the blood, where the two infrared wavelengths are symmetrically disposed on different sides of the isobestic point.
12. A method according to claim 9 and wherein the determination of oxygen saturation includes the step of calculating the ratio of the measurement of step b) to the measurement of step a) .
13. A method of determining oxygen saturation in blood in a blood circuit comprising the following steps:
a) repeatedly measuring light at a wavelength in the red range reflected from the blood as it passes through the blood circuit; b) repeatedly measuring light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit;
c) repeatedly calculating oxygen saturation in the blood based on the measurements taken in steps a) and b), using a different formula for the determination of oxygen saturation depending on the level of hematocrit in the blood.
14. A method according to claim 13 and further including a step d) of repeatedly calculating hematocrit level in the blood as it passes through the blood circuit e) of repeatedly providing red light to the blood, and f) of repeatedly providing infrared light to the blood, and wherein the calculation of oxygen saturation is based on the measurement taken in steps a) and, b) , and the calculation of step d), so that the oxygen saturation calculation includes a correction for the hematocrit level of the blood passing through the circuit.
15. A method according to claim 14 and wherein the calculation of hematocrit is based on the measurement of step b) only.
16. A method according to claim 15 and wherein hematocrit is determined using a calculation based on an approximation of the amount of reflected light at the isobestic point on the reflection curves of deoxy and oxyhemoglobin.
17. A method according to claim 16 and further including the steps g) of repeatedly providing light at a second infrared wavelength to the blood and h) repeatedly measuring the amount of the second infrared wavelength reflected from the blood, where the two infrared wavelengths are symmetrically disposed on different sides of the isobestic point.
18. A method according to claim 4, 11, and 17 and wherein the approximation of the amount of light reflected at the isobestic point is made according to the following formula, where R represents the amount of reflected light at the specified wavelength: 19. A method according to claim 4, 11, and 17 and wherein the approximation of the amount of light reflected at the isobestic point is made according to the following formula, where R represents the amount of reflected light at the specified wavelength:
RISOBESTIC = RFIRST INFRARED X RSECOND INFRARED
20. A method according to claim 2, 9 or 13 and wherein hematocrit is determined using the following formula, where A, B, C, and D are constants and RBOBESΉC represents the amount of light reflected from the blood at the isobestic point on the reflection curve of oxy- and deoxyhemoglobin:
21. A method according to claim 2, 9 or 13 and wherein hematocrit is determined using the following formula, where L and M are constants and RISOBESTIC represents the amount of light reflected from the blood at the isobestic wavelength:
22. A method according to claims 2, 9 or 15 and wherein the wavelength of the red radiation is at about 660 nm.
23. A method according to claims 4, 11, or 17 and wherein the first infrared wavelength is about 810 nm and the second infrared wavelength is about 830 nm.
24. A method according to claim 15 and wherein the determination of oxygen saturation includes the step of calculating the ratio of the measurement of step b) to the measurement of step a).
25. A method according to claim 24 and wherein different formulas are used in the calculation of oxygen saturation according to the hematocrit level.
26. A method according to claim 9 or 16 and wherein for a given hematocrit range, the oxygen saturation formula is selected according to the level of oxygen saturation from the following group of formulas, where A1, B1, C3, D1, A2, B2, C2, A3, B3, C3, D3, A4, B4, C4 and D4 are constants, and Ratio is the ratio of the infrared measurement to the red measurement:
27. A method according to claim 9 or 16 and wherein for a given hematocrit range, the oxygen saturation formula is selected according to the level of oxygen saturation from the following group of formulas, where A5, B5, C5, D5, A6, B6, C6, D6, A7, B7, C7, D7, A8, B8, C8, and D8 are constants, and Ratio is the ratio of the infrared measurement to the red measurement:
28. A method according to claim 9 or 16 and wherein for a given hematocrit range, the oxygen saturation formula is selected according to the level of oxygen saturation from the following group of formulas, where A9, B9, C9, D9, A10, B10, C10,
D10, E10, A11, B11, C11, D11, A12, B12, C12, and D12 are constants, and
Ratio is the ratio of the infrared measurement to the red measurement:
29. A method according to claim 9 or 16 and wherein for a given hematocrit range, the oxygen saturation formula is selected according to the. level of oxygen saturation from the following group of formulas, where A13, B13, C13, D13, A14, B14, C14, D14, A15, B15, C15, D15, A16, B16, and C16 are constants, and Ratio is the ratio of the infrared measurement to the red measurement:
and
30. A method according to claim 9 or 16 and wherein for a given oxygen saturation range, the oxygen saturation formula is selected according to the level of hematocrit, where A1, B1, C1, D1, A5, B5, C5, D5, A9, B9, C9, D9, A13, B13, C13 and D13 are constants and Ratio is the ratio of the infrared measurement to the red measurement:
31. A method according to claim 9 or 16 and wherein for a given oxygen saturation range, the oxygen saturation formula is selected according to the level of hematocrit, where A3, B3, C3, D3, A7, B7, C7, D7, A11, B11, C11, D11, A15, B15, C15 and D15 are constants and Ratio is the ratio of the infrared measurement to the red measurement:
32. A method according to claim 9 or 16 and wherein for a given oxygen saturation range, the oxygen saturation formula is selected according to the level of hematocrit, where A2, B2, C2, A6, B6, C6, D6, A10, B10, C10, D10, A16, B16, and C16 are constants and Ratio is the ratio of the infrared measurement to the red measurement:
33. A method according to claim 9 or 16 and wherein for a given oxygen saturation range, the oxygen saturation formula is selected according to the level of hematocrit, where A4, B4, C4, D4, A8, B8, C8, D8, A12, B12, C12, D12, A14, B14, C16 and D16 are constants and Ratio is the ratio of the infrared measurement to the red measurement:
34. A method of determining oxygen saturation of the blood comprising the following steps:
providing infrared light to the blood;
providing red light to the blood;
measuring the amount of infrared light returned from the blood;
measuring the amount of red light returned from the blood;
utilizing the measurement of infrared light to calculate hematocrit; and
calculating oxygen saturation using the following formula, where E, F, G, H, I, J, and K are constants, R is the ratio of the measurement of infrared to red light returned, and Hct is the percent hematocrit:
sO2 = E·ratio + F/ratio + G/(ratio2) +
H·ratio/Hct + I·Hct + J/Hct + K/(Hct2)
35. A method of determining oxygen saturation to the blood comprising the following steps:
providing infrared light to the blood;
providing red light to the blood; measuring the amount of infrared light returned from the blood;
measuring the amount of red light returned from the blood;
utilizing the measurement of infrared light to calculate hematocrit; and
calculating oxygen saturation using the following formula, where N, O, P, Q, S, and T are constants, Ratio is the ratio of the measurement of infrared to red light returned, and Hct is the percent hematocrit:
sO2 = N-Ratio + O/Ratio + P/(Ratio2) +
Q·Ratio/Hct + S·Hct + T·Ln(Hct)
36. Apparatus for determining oxygen saturation in blood passing through a blood circuit comprising:
means for repeatedly providing light to the blood as it passes through the blood circuit;
means for repeatedly receiving light reflected from the blood at a single distance from the provided light;
means for repeatedly utilizing the received light to approximate the amount of light reflected from the blood at the isobestic wavelength of oxy- and deoxyhemoglobin;
means for repeatedly calculating the hematocrit level of the blood passing through the blood circuit based on the amount of light reflected from the blood at the isobestic wavelength; and means for repeatedly calculating oxygen saturation in the blood passing through the blood circuit based on the amount of light reflected from the blood and the calculation of hematocrit so that the oxygen saturation determination includes a correction for the hematocrit level of the blood passing through the circuit, calculated according to the amount of light reflected at the isobestic wavelength of oxy- and deoxyhemoglobin.
37. Apparatus according to claim 36 and further comprising: means for repeatedly providing light at a red wavelength to the blood, wherein said first means for providing light provides light at an infrared wavelength;
means for repeatedly measuring the amount of red light reflected from the blood as the blood passes through the blood circuit; and
means for repeatedly measuring the amount of infrared light reflected from the blood as it passes through the blood circuit
wherein the means for calculating oxygen saturation utilizes the measurements of red and infrared light.
38. Apparatus according to claim 37 and wherein the means for repeatedly providing light are light-emitting diodes, the means for measuring the amount of light is a photodiode and the means for calculating is comprised of software.
39. Apparatus according to claim 38 and wherein the blood is passed through a cuvette, the light-emitting diodes provide light to the blood through fiber-optic cables, and the photodiode receives light through a fiber-optic cable.
40. Apparatus according to claim 38 and further including an LED emitting light at a second infrared wavelength to the blood, where the two infrared wavelengths are symmetrically disposed on different sides of the isobestic point.
41. Apparatus according to claim 37 and including software to calculate oxygen saturation level according to the following formula, where E, F, G, H, I, J, and K are constants, Hct is percent hematocrit, and ratio is the ratio of reflected light at the infrared range to that at the red range:
sO2 = E·ratio + F/ratio + G/(ratio2) + H·ratio/Hct + I·Hct + J/Hct + K/(Hct2)
42. Apparatus according to claim 37 and including software to calculate oxygen saturation level according to the following formula, where N, O, P, Q, S, and T are constants, Hct is percent hematocrit, and Ratio is the ratio of reflected light at the infrared range to that at the red range:
sO2 = N·Ratio + O/Ratio + P/(Ratio2) +
Q·Ratio/Hct + S·Hct + T·Ln(Hct)
43. Apparatus according to claim 38 and wherein the software provides more than one formula for the determination of oxygen saturation according to the level of hematocrit.
44. Apparatus according to claim 38 and wherein the software provides more than one formula for the determination of oxygen saturation according to the oxygen saturation level.
45. Apparatus for determining oxygen saturation of blood in a blood circuit comprising:
means for repeatedly measuring light at a wavelength in the red range, of the blood as it passes through the blood circuit;
means for repeatedly measuring reflected light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit;
means for repeatedly calculating hematocrit level in the blood as it passes through the blood circuit based on the measurements of step b); and
means for repeatedly determining oxygen saturation in the blood based on the measurements, and the calculation of hematocrit, and selecting a different formula for the determination according to the level of oxygen saturation.
46. Apparatus according to claim 45 and wherein the means for determining oxygen saturation includes means for selecting a different formula according to the level of hematocrit.
47. A method according to claim 9 wherein the hematocrit level is calculated based on an approximation of the amount of light reflected at the isobestic wavelength on the reflection curve of oxy- and deoxyhemoglobin.
48. Apparatus according to claim 46 and wherein the means for calculating hematocrit includes means for calculating using an approximation of the amount of light reflected at the isobestic wavelength of oxy- and deoxyhemoglobin.
49. Apparatus according to claim 48 and wherein the wavelength in the infrared range is at the isobestic wavelength.
50. Apparatus according to claim 46 and wherein the means for calculating oxygen saturation includes means for calculating the ratio of the measurement of infrared light to the measurement of red light.
51. Apparatus according to claim 48 and wherein the means for repeatedly providing light are light-emitting diodes, the means for measuring the amount of light is a photodiode, and the means for calculating is comprised of software.
52. Apparatus according to claim 51 and wherein the blood is passed through a cuvette, the light-emitting diodes provide light to the blood through fiber-optic cables, and the photodiode receives light through a fiber-optic cable.
53. Apparatus according to claim 51 and further including an LED emitting light at a second infrared wavelength to the blood, where the two infrared wavelengths are symmetrically disposed on different sides of the isobestic wavelength.
54. Apparatus for determining oxygen saturation in blood in a blood circuit comprising:
means for repeatedly measuring light at a wavelength in the red range reflected from the blood as it passes through the blood circuit;
means for repeatedly measuring light at a wavelength in the infrared range reflected from the blood as it passes through the blood circuit; and
means for repeatedly calculating oxygen saturation in the blood based on the measurements, using a different formula for the determination of oxygen saturation according to the level of hematocrit in the blood.
55. Apparatus according to claim 54 and further comprising means for repeatedly calculating hematocrit level of the blood as it passes through the blood circuit and wherein the means for calculating oxygen saturation includes means for correcting the oxygen saturation calculation for the hematocrit level.
56. Apparatus according to claim 55 further comprising means for providing red light to the blood and means for providing infrared light to the blood, and wherein the means for calculating hematocrit includes a means for approximating the amount of reflected light at the isobestic wavelength on the reflection curves of deoxy- and oxyhemoglobin.
57. Apparatus according to claim 55 and wherein the means for repeatedly providing light are light-emitting diodes, the means for measuring the amount of light is a photodiode, and the means for calculating is comprised of software .
58. Apparatus according to claim 55 and wherein the blood is passed through a cuvette, the light-emitting diodes provide light to the blood through fiber-optic cables, and the photodiode receives light through a fiber-optic cable.
59. Apparatus according to claim 58 and further comprising a light-emitting diode for providing light at a second infrared wavelength to the blood and means for repeatedly measuring the amount of the second infrared wavelength reflected from the blood, where the two infrared wavelengths are symmetrically disposed on different sides of the isobestic point.
60. Apparatus according to claim 38, 51 or 58 and wherein the light-emitting diodes emit light sequentially, and a central processing unit controls the apparatus.
61. Apparatus according to claim 38, 51 or 58 and wherein the red light is at about 660 nm and the infrared light is at about 830 nm, and a separate light-emitting diode provides light to the blood at about 810 nm.
62. Apparatus according to claim 39, 52 or 58 and wherein the red light is at about 660 nm and the infrared light is at about the isobestic point on the reflection curve of oxy- and deoxyhemoglobin.
63. Apparatus according to claim 39, 52 or 58 and wherein the providing fiber-optic cables are all equidistant from the receiving fiber-optic cable.
64. Apparatus according to claim 48, 51 or 59 and wherein the software provides an approximation of the amount of light reflected at the isobestic point according to the following formula, where R equals the amount of reflected light:
65. A method according to claim 48, 51 or 59 and wherein software provides an approximation of the amount of light reflected at the isobestic point according to the following formula, where R equals the amount of reflected light:
RISOBESTIC = RFIRST INFRARED X RSECOND INFRARED
66. Apparatus according to claim 38, 51 or 58 and wherein the software provides a calculation of hematocrit according to the following formula:
67. Apparatus according to claim 38, 51 or 58 and wherein the software provides a calculation of hematocrit according to the following formula where L and M are constants and RISOBESTIC approximates the amount of light reflected from the blood at the isobestic wavelength:
Hct = Exp (L · RISOBESTIC + M/Ln (RISOBESTIC 2) )
68. Apparatus according to claim 39, 52 or 58 and wherein the providing fiber-optic cables are equidistant from the receiving fiber-optic cable.
PCT/US1992/008396 1991-10-03 1992-10-01 Method and apparatus for determining oxygen saturation WO1993006775A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US77128791 true 1991-10-03 1991-10-03
US771,287 1991-10-03

Publications (1)

Publication Number Publication Date
WO1993006775A1 true true WO1993006775A1 (en) 1993-04-15

Family

ID=25091332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/008396 WO1993006775A1 (en) 1991-10-03 1992-10-01 Method and apparatus for determining oxygen saturation

Country Status (1)

Country Link
WO (1) WO1993006775A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037800A1 (en) * 1997-02-27 1998-09-03 Minnesota Mining And Manufacturing Company Cassette for tonometric calibration
WO1998037802A1 (en) * 1997-02-27 1998-09-03 Minnesota Mining And Manufacturing Company Blood parameter measurement device
US5958782A (en) * 1993-10-21 1999-09-28 Minnesota Mining And Manufacturing Company Cation-sensing composite structure and compounds for use therein
US6101406A (en) * 1997-02-27 2000-08-08 Terumo Cardiovascular Systems Corporation Cassette for measuring parameters of blood
US6801797B2 (en) * 2000-04-17 2004-10-05 Nellcor Puritan Bennett Incorporated Pulse oximeter sensor with piece-wise function
US7085597B2 (en) 2000-08-31 2006-08-01 Mallinckrodt, Inc. Oximeter sensor with digital memory recording sensor data
US7648475B2 (en) 2001-12-28 2010-01-19 Gambro Lundia Ab Non-invasive device for measuring blood temperature in a circuit for the extracorporeal circulation of blood, and equipment provided with this device
US8060170B2 (en) 2000-08-31 2011-11-15 Tyco Healthcare Group Method and circuit for storing and providing historical physiological data
CN105536086A (en) * 2016-02-23 2016-05-04 南京医科大学第一附属医院 Multifunctional ECMO circulating pipeline and method for performing extracorporeal membrane oxygenation by utilizing multifunctional ECMO circulating pipeline

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4651741A (en) * 1985-05-30 1987-03-24 Baxter Travenol Laboratories, Inc. Method and apparatus for determining oxygen saturation in vivo
US4745279A (en) * 1986-01-02 1988-05-17 American Hospital Supply Corporation Hematocrit measuring apparatus
US4776340A (en) * 1987-03-23 1988-10-11 Spectramed, Inc. Hematocrit measurement by differential optical geometry in a short-term diagnostic cardiovascular catheter, and application to correction of blood-oxygen measurement
WO1990007905A1 (en) * 1989-01-19 1990-07-26 Futrex, Inc. Non-invasive measurement of blood glucose
EP0380664A1 (en) * 1987-07-24 1990-08-08 Terumo Kabushiki Kaisha Apparatus for measuring concentration and oxygen saturation of hemoglobin
US5048524A (en) * 1989-03-03 1991-09-17 Camino Laboratories, Inc. Blood parameter measurement
US5066859A (en) * 1990-05-18 1991-11-19 Karkar Maurice N Hematocrit and oxygen saturation blood analyzer

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4651741A (en) * 1985-05-30 1987-03-24 Baxter Travenol Laboratories, Inc. Method and apparatus for determining oxygen saturation in vivo
US4745279A (en) * 1986-01-02 1988-05-17 American Hospital Supply Corporation Hematocrit measuring apparatus
US4776340A (en) * 1987-03-23 1988-10-11 Spectramed, Inc. Hematocrit measurement by differential optical geometry in a short-term diagnostic cardiovascular catheter, and application to correction of blood-oxygen measurement
EP0380664A1 (en) * 1987-07-24 1990-08-08 Terumo Kabushiki Kaisha Apparatus for measuring concentration and oxygen saturation of hemoglobin
WO1990007905A1 (en) * 1989-01-19 1990-07-26 Futrex, Inc. Non-invasive measurement of blood glucose
US5048524A (en) * 1989-03-03 1991-09-17 Camino Laboratories, Inc. Blood parameter measurement
US5066859A (en) * 1990-05-18 1991-11-19 Karkar Maurice N Hematocrit and oxygen saturation blood analyzer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 15, no. 140 (P-1188)9 April 1991 & JP,A,30 18 742 ( TERUMO CORP ) *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958782A (en) * 1993-10-21 1999-09-28 Minnesota Mining And Manufacturing Company Cation-sensing composite structure and compounds for use therein
WO1998037802A1 (en) * 1997-02-27 1998-09-03 Minnesota Mining And Manufacturing Company Blood parameter measurement device
US5997818A (en) * 1997-02-27 1999-12-07 Minnesota Mining And Manufacturing Company Cassette for tonometric calibration
US6101406A (en) * 1997-02-27 2000-08-08 Terumo Cardiovascular Systems Corporation Cassette for measuring parameters of blood
US6208880B1 (en) 1997-02-27 2001-03-27 Terumo Cardiovascular Systems Corporation Blood parameter measurement device
WO1998037800A1 (en) * 1997-02-27 1998-09-03 Minnesota Mining And Manufacturing Company Cassette for tonometric calibration
EP2322085A1 (en) * 2000-04-17 2011-05-18 Nellcor Puritan Bennett Incorporated Pulse oximeter sensor with piece-wise function
US6801797B2 (en) * 2000-04-17 2004-10-05 Nellcor Puritan Bennett Incorporated Pulse oximeter sensor with piece-wise function
EP2684514A1 (en) * 2000-04-17 2014-01-15 Covidien LP Pulse oximeter sensor with piece-wise function
US7085597B2 (en) 2000-08-31 2006-08-01 Mallinckrodt, Inc. Oximeter sensor with digital memory recording sensor data
US8060170B2 (en) 2000-08-31 2011-11-15 Tyco Healthcare Group Method and circuit for storing and providing historical physiological data
US9844348B2 (en) 2000-08-31 2017-12-19 Coviden Lp Method and circuit for storing and providing historical physiological data
US7648475B2 (en) 2001-12-28 2010-01-19 Gambro Lundia Ab Non-invasive device for measuring blood temperature in a circuit for the extracorporeal circulation of blood, and equipment provided with this device
CN105536086A (en) * 2016-02-23 2016-05-04 南京医科大学第一附属医院 Multifunctional ECMO circulating pipeline and method for performing extracorporeal membrane oxygenation by utilizing multifunctional ECMO circulating pipeline

Similar Documents

Publication Publication Date Title
Fantini et al. Frequency-domain multichannel optical detector for noninvasive tissue spectroscopy and oximetry
Webster Design of pulse oximeters
US5127406A (en) Apparatus for measuring concentration of substances in blood
US5402778A (en) Spectrophotometric examination of tissue of small dimension
US6230035B1 (en) Apparatus for determining concentrations of light-absorbing materials in living tissue
Heise et al. Noninvasive blood glucose sensors based on near‐infrared spectroscopy
Burmeister et al. Evaluation of measurement sites for noninvasive blood glucose sensing with near-infrared transmission spectroscopy
US6018674A (en) Fast-turnoff photodiodes with switched-gain preamplifiers in photoplethysmographic measurement instruments
US6510330B1 (en) Method and device for measuring blood parameters
US6952603B2 (en) Subcutaneous analyte sensor
US6393310B1 (en) Methods and systems for clinical analyte determination by visible and infrared spectroscopy
US4805623A (en) Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment
US5692504A (en) Method and apparatus for the analysis of glucose in a biological matrix
US6647279B2 (en) Hybrid optical delivery system for photoplethysmography
US4922919A (en) Method for measuring ocular oxidative metabolism
US5243983A (en) Non-invasive blood glucose measurement system and method using stimulated raman spectroscopy
US7254432B2 (en) Method and device for non-invasive measurements of blood parameters
US7010336B2 (en) Measurement site dependent data preprocessing method for robust calibration and prediction
US20040181131A1 (en) Determination of pH including hemoglobin correction
Liu et al. Influence of blood vessels on the measurement of hemoglobin oxygenation as determined by time‐resolved reflectance spectroscopy
US5280786A (en) Fiberoptic blood pressure and oxygenation sensor
US6438397B1 (en) Method and apparatus for analyte detection using intradermally implanted skin port
US20120271131A1 (en) Mucosal sensor for the assessment of tissue and blood constituents and technique for using the same
US6061583A (en) Noninvasive blood analyzer
US20060211931A1 (en) Noninvasive analyzer sample probe interface method and apparatus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA